During the past decade, Hatton Research Institutes conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hatton Research Institutes" are "Glioblastoma" (2 trials), "Peripheral Arterial Disease" (1 trials) and "Tachyarrhythmia" (1 trials). Many other conditions were trialed in "Hatton Research Institutes" in a lesser frequency.

Most popular intervention types in "Hatton Research Institutes" are "Device" (2 trials), "Drug" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (2 trials), "Placebo" (2 trials), "Atherectomy Catheter" (1 trials), "Defibrillation" (1 trials) and "Onartuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hatton Research Institutes" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hatton Research Institutes". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hatton Research Institutes, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hatton Research Institutes, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".